Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""von Willebrand Disease, Type 1"" wg kryterium: Temat


Tytuł:
A decreased and less sustained response to surrogates of haemostatic stress correlates with bleeding in type 1 von Willebrand disease.
Autorzy:
Kloosterman R; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada.
Zago-Schmitt M; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada.
Grabell J; Department of Medicine, Queen's University, Kingston, Ontario, Canada.
Thibeault L; Kingston Health Sciences Centre, Kingston, Ontario, Canada.
Chaigneau M; Department of Medicine, Queen's University, Kingston, Ontario, Canada.
Hinds M; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada.
Hopman W; Clinical Research Institute, Kingston General Hospital, Kingston, Ontario, Canada.; Department of Public Health Sciences, Queen's University, Kingston, Ontario, Canada.
Bowman M; Department of Medicine, Queen's University, Kingston, Ontario, Canada.
Harpell L; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada.
Johri AM; Department of Medicine, Queen's University, Kingston, Ontario, Canada.
Good D; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada.
James P; Department of Medicine, Queen's University, Kingston, Ontario, Canada.
Pokaż więcej
Źródło:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2023 Jan; Vol. 29 (1), pp. 370-373. Date of Electronic Publication: 2022 Nov 26.
Typ publikacji:
Letter
MeSH Terms:
Hemostatics*/therapeutic use
von Willebrand Disease, Type 1*/complications
von Willebrand Diseases*/complications
Humans ; Hemorrhage/complications ; Hemostasis ; von Willebrand Factor
Opinia redakcyjna
Tytuł:
Quantification of the relationship between desmopressin concentration and Von Willebrand factor in Von Willebrand disease type 1: A pharmacodynamic study.
Autorzy:
Heijdra JM; Department of Paediatric Haematology, Erasmus MC Sophia Children's Hospital, University Medical Centre Rotterdam, The Netherlands.
Cloesmeijer ME; Department of Hospital Pharmacy - Clinical Pharmacology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
de Jager NCB; Department of Hospital Pharmacy - Clinical Pharmacology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Leebeek FWG; Department of Haematology, Erasmus MC, Erasmus University Medical Centre Rotterdam, The Netherlands.
Kruip MHJA; Department of Haematology, Erasmus MC, Erasmus University Medical Centre Rotterdam, The Netherlands.
Cnossen MH; Department of Paediatric Haematology, Erasmus MC Sophia Children's Hospital, University Medical Centre Rotterdam, The Netherlands.
Mathôt RAA; Department of Hospital Pharmacy - Clinical Pharmacology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Pokaż więcej
Corporate Authors:
OPTI-CLOT/ To WiN study group and SYMPHONY consortium; Department of Paediatric Haematology, Erasmus MC Sophia Children's Hospital, University Medical Centre Rotterdam, The Netherlands.
Źródło:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2022 Sep; Vol. 28 (5), pp. 814-821. Date of Electronic Publication: 2022 May 08.
Typ publikacji:
Journal Article
MeSH Terms:
von Willebrand Disease, Type 1*/drug therapy
von Willebrand Diseases*/drug therapy
Adult ; Deamino Arginine Vasopressin/pharmacology ; Deamino Arginine Vasopressin/therapeutic use ; Factor VIII/therapeutic use ; Humans ; von Willebrand Factor/therapeutic use
Czasopismo naukowe
Tytuł:
Emicizumab enhances thrombus formation in vitro under high shear flow conditions in whole blood from patients with type 1 and type 3 von Willebrand disease.
Autorzy:
Yaoi H; Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan.
Shida Y; Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan.
Ogiwara K; Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan.
Kitazawa T; Research Division, Chugai Pharmaceutical Co., Gotemba, Shizuoka, Japan.
Shima M; Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan.; Thrombosis and Hemostasis Research Center, Nara Medical University, Japan.
Nogami K; Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan.
Pokaż więcej
Źródło:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2022 Sep; Vol. 28 (5), pp. 694-701. Date of Electronic Publication: 2022 Apr 27.
Typ publikacji:
Journal Article
MeSH Terms:
Thrombosis*/drug therapy
von Willebrand Disease, Type 1*
von Willebrand Disease, Type 3*/drug therapy
von Willebrand Diseases*/drug therapy
Antibodies, Bispecific ; Antibodies, Monoclonal, Humanized ; Factor VIII/therapeutic use ; Humans ; von Willebrand Factor/therapeutic use
Czasopismo naukowe
Tytuł:
Social participation is reduced in type 3 Von Willebrand disease patients and in patients with a severe bleeding phenotype.
Autorzy:
Kempers EK; Department of Haematology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands.
van Kwawegen CB; Department of Haematology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands.
de Meris J; Netherlands Haemophilia Society, Leiden, The Netherlands.
Schols SEM; Department of Haematology, Radboud University Medical Centre, Nijmegen and Haemophilia Treatment Centre Nijmegen-Eindhoven-Maastricht, Nijmegen, The Netherlands.
van Galen KPM; Department van Creveldkliniek, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.
Meijer K; Department of Haematology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
Cnossen MH; Department of Paediatric Haematology and Oncology, Erasmus MC Sophia Children's Hospital, University Medical Centre Rotterdam, Rotterdam, The Netherlands.
van der Bom JG; Department of Clinical Epidemiology, Leiden University Medical Centre, Leiden, The Netherlands.; Jon J. van Rood Centre for Clinical Transfusion Medicine, Sanquin Research, Leiden, The Netherlands.
Fijnvandraat K; Amsterdam UMC, University of Amsterdam, Emma Children's Hospital, Paediatric Haematology, Amsterdam, The Netherlands.; Sanquin Research, Department of Molecular Cellular Haemostasis, Amsterdam, The Netherlands.
Eikenboom J; Department of Internal Medicine, Division of Thrombosis and Haemostasis, Leiden University Medical Centre, Leiden, The Netherlands.; Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Centre, Leiden, The Netherlands.
Atiq F; Department of Haematology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands.
Leebeek FWG; Department of Haematology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands.
Pokaż więcej
Corporate Authors:
WiN study group
Źródło:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2022 Mar; Vol. 28 (2), pp. 278-285. Date of Electronic Publication: 2021 Dec 29.
Typ publikacji:
Journal Article
MeSH Terms:
von Willebrand Disease, Type 1*/complications
von Willebrand Disease, Type 3*/complications
von Willebrand Diseases*/complications
Adolescent ; Adult ; Female ; Hemorrhage/complications ; Humans ; Male ; Phenotype ; Social Participation ; von Willebrand Factor/genetics
Czasopismo naukowe
Tytuł:
Impact of obesity on factor VIII and von Willebrand factor levels in patients with Type 1 von Willebrand disease and low von Willebrand factor: An analysis of the ATHNdataset.
Autorzy:
Schaefer BA; University at Buffalo, Roswell Park Oishei Children's Cancer and Blood Disorders Program, Buffalo, NY, USA.; Western New York BloodCare, Buffalo, New York, USA.
Cheng D; American Thrombosis and Hemostasis Network, Rochester, New York, USA.
Kouides P; University of Rochester School of Medicine, Mary M. Gooley Hemophilia Treatment Center, Rochester, New York, USA.
Pokaż więcej
Źródło:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2022 Jan; Vol. 28 (1), pp. 109-116. Date of Electronic Publication: 2021 Dec 07.
Typ publikacji:
Journal Article
MeSH Terms:
Hemostatics*
von Willebrand Disease, Type 1*
von Willebrand Diseases*/complications
von Willebrand Diseases*/epidemiology
Adolescent ; Child ; Factor VIII ; Humans ; Obesity/complications ; Obesity/epidemiology ; Retrospective Studies ; von Willebrand Factor
Czasopismo naukowe
Tytuł:
The effect of age at diagnosis of type 1 von Willebrand disease on diagnostic laboratory values: A paediatric perspective.
Autorzy:
Sampson ME; Akron Children's Hospital, Akron, Ohio, USA.
Cheng D; American Thrombosis and Hemostasis Network, Rochester, New York, USA.
Recht M; American Thrombosis and Hemostasis Network, Rochester, New York, USA.; Oregon Health & Science University, Portland, Oregon, USA.
Fargo JH; Akron Children's Hospital, Akron, Ohio, USA.
Pokaż więcej
Źródło:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2021 May; Vol. 27 (3), pp. e412-e414. Date of Electronic Publication: 2021 Feb 03.
Typ publikacji:
Letter
MeSH Terms:
von Willebrand Disease, Type 1*/diagnosis
von Willebrand Diseases*/diagnosis
Child ; Humans ; Laboratories ; von Willebrand Factor
Opinia redakcyjna
Tytuł:
Quantitative analysis of desmopressin (DDAVP) response in adult patients with type 1 von Willebrand disease.
Autorzy:
Guddati AK; Division of Hematology and Oncology, Georgia Cancer Center, Augusta University, Augusta, Georgia.
Rosovsky RP; Division of Hematology, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts.
Van Cott EM; Department of Pathology, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts.
Kuter DJ; Division of Hematology, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts.
Pokaż więcej
Źródło:
International journal of laboratory hematology [Int J Lab Hematol] 2019 Jun; Vol. 41 (3), pp. 325-330. Date of Electronic Publication: 2019 Feb 08.
Typ publikacji:
Journal Article
MeSH Terms:
Deamino Arginine Vasopressin/*therapeutic use
von Willebrand Disease, Type 1/*blood
von Willebrand Disease, Type 1/*drug therapy
Adult ; Biomarkers ; Blood Coagulation ; Blood Coagulation Factors ; Blood Coagulation Tests/methods ; Deamino Arginine Vasopressin/administration & dosage ; Female ; Hemostatics/pharmacokinetics ; Hemostatics/therapeutic use ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Time Factors ; Treatment Outcome ; von Willebrand Disease, Type 1/diagnosis ; von Willebrand Factor
Czasopismo naukowe
Tytuł:
Whole blood ristocetin-induced platelet impedance aggregometry does not reflect clinical severity in patients with type 1 von Willebrand disease.
Autorzy:
Nakajima Y; Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan.
Nogami K; Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan.
Yada K; Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan.; The Course of Hemophilia Education, Nara Medical University, Kashihara, Nara, Japan.
Ogiwara K; Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan.
Furukawa S; Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan.; The Course of Thrombosis and Hemostasis Molecular Pathology, Nara Medical University, Kashihara, Nara, Japan.
Shimonishi N; Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan.
Shima M; Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan.
Pokaż więcej
Źródło:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2019 May; Vol. 25 (3), pp. e174-e179. Date of Electronic Publication: 2019 Mar 13.
Typ publikacji:
Journal Article
MeSH Terms:
Severity of Illness Index*
Platelet Aggregation/*drug effects
Ristocetin/*pharmacology
von Willebrand Disease, Type 1/*physiopathology
Adolescent ; Adult ; Case-Control Studies ; Electric Impedance ; Female ; Humans ; Male ; Middle Aged ; Phenotype ; Ristocetin/blood ; Young Adult ; von Willebrand Disease, Type 1/blood ; von Willebrand Disease, Type 1/metabolism ; von Willebrand Factor/metabolism
Czasopismo naukowe
Tytuł:
Anesthetic Management of a Patient With Type 1 von Willebrand Disease and Uterine Placental Abruption: A Case Report.
Autorzy:
Roberson MC; is a staff nurse anesthetist at Mississippi Baptist Medical Center in Jackson, Mississippi.
Wigley MD; is a staff nurse at Mississippi Baptist Medical Center.
Austin PN; is a professor of nurse anesthesia in the Doctor of Nurse Anesthesia Practice program at Texas Wesleyan University, Fort Worth, Texas.
Pokaż więcej
Źródło:
AANA journal [AANA J] 2018 Jun; Vol. 86 (3), pp. 209-212.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Perinatal Care*
Pregnancy Complications, Hematologic*
von Willebrand Disease, Type 1*
Abruptio Placentae/*diagnosis
Abruptio Placentae/nursing ; Adult ; Anesthesia, Obstetrical ; Cesarean Section ; Deamino Arginine Vasopressin/administration & dosage ; Diagnosis, Differential ; Female ; Humans ; Nurse Anesthetists ; Pregnancy ; Pregnancy Outcome
Czasopismo naukowe
Tytuł:
Inheritance of von Willebrand disease Vicenza in a Japanese family.
Autorzy:
Shigekiyo T; Department of Hematology, Tokushima Prefectural Central Hospital, Tokushima, Japan.
Udaka K; Department of Hematology, Tokushima Prefectural Central Hospital, Tokushima, Japan.
Sekimoto E; Department of Hematology, Tokushima Prefectural Central Hospital, Tokushima, Japan.
Shibata H; Department of Hematology, Tokushima Prefectural Central Hospital, Tokushima, Japan.
Ozaki S; Department of Hematology, Tokushima Prefectural Central Hospital, Tokushima, Japan.
Takeda M; Department of Ophthalmology, Tokushima Prefectural Central Hospital, Tokushima, Japan.
Aihara K; Department of Hematology, Endocrinology and Metabolism, Institute of Biomedical Science, Tokushima University Graduated School, Tokushima, Japan.
Pokaż więcej
Źródło:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2018 May; Vol. 24 (3), pp. e131-e133. Date of Electronic Publication: 2018 Mar 26.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Hemophilia A/*genetics
Mutation/*genetics
von Willebrand Disease, Type 1/*genetics
von Willebrand Factor/*genetics
DNA Mutational Analysis ; Databases, Genetic ; Hemophilia A/diagnosis ; Humans ; Japan ; Male ; Middle Aged ; Partial Thromboplastin Time ; Pedigree ; von Willebrand Disease, Type 1/diagnosis
Raport
Tytuł:
Controversies in the diagnosis of Type 1 von Willebrand disease.
Autorzy:
Bowman ML; Department of Medicine, Queen's University, Kingston, ON, Canada.
James PD; Department of Medicine, Queen's University, Kingston, ON, Canada.; Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON, Canada.
Pokaż więcej
Źródło:
International journal of laboratory hematology [Int J Lab Hematol] 2017 May; Vol. 39 Suppl 1, pp. 61-68.
Typ publikacji:
Journal Article; Review
MeSH Terms:
von Willebrand Disease, Type 1/*diagnosis
Hemorrhage/blood ; Hemorrhage/diagnosis ; Hemorrhage/genetics ; Humans ; Phenotype ; von Willebrand Disease, Type 1/blood ; von Willebrand Disease, Type 1/genetics
Czasopismo naukowe
Tytuł:
von Willebrand disease type 1 mutation p.Arg1379Cys and the variant p.Ala1377Val synergistically determine a 2M phenotype in four Italian patients.
Autorzy:
Pagliari MT; Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico and Fondazione Luigi Villa, Milan, Italy.
Baronciani L; Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico and Fondazione Luigi Villa, Milan, Italy.
Stufano F; Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico and Fondazione Luigi Villa, Milan, Italy.
Garcia-Oya I; Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico and Fondazione Luigi Villa, Milan, Italy.
Cozzi G; Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico and Fondazione Luigi Villa, Milan, Italy.
Franchi F; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
Peyvandi F; Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico and Fondazione Luigi Villa, Milan, Italy.; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
Pokaż więcej
Źródło:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2016 Nov; Vol. 22 (6), pp. e502-e511. Date of Electronic Publication: 2016 Oct 26.
Typ publikacji:
Journal Article
MeSH Terms:
Mutation*
von Willebrand Disease, Type 1/*genetics
von Willebrand Factor/*genetics
Female ; Humans ; Italy ; Male ; Phenotype ; von Willebrand Disease, Type 1/metabolism ; von Willebrand Factor/metabolism
Czasopismo naukowe
Tytuł:
Identification of von Willebrand disease type 1 in a patient with Ehlers-Danlos syndrome classic type.
Autorzy:
Ott HW; Department of Hemostasis and Transfusion Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany.
Perkhofer S; University of Applied Sciences Tyrol, Innsbruck, Austria.
Coucke PJ; Center for Medical Genetics, University Hospital Ghent, Gent, Belgium.
de Paepe A; Center for Medical Genetics, University Hospital Ghent, Gent, Belgium.
Spannagl M; Department of Hemostasis and Transfusion Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany.
Pokaż więcej
Źródło:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2016 Jul; Vol. 22 (4), pp. e309-11. Date of Electronic Publication: 2016 Jun 13.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Ehlers-Danlos Syndrome/*diagnosis
von Willebrand Disease, Type 1/*diagnosis
Adult ; Alleles ; Collagen Type V/genetics ; Ehlers-Danlos Syndrome/complications ; Ehlers-Danlos Syndrome/genetics ; Ehlers-Danlos Syndrome/pathology ; Factor VIII/analysis ; Female ; Fibroblasts/cytology ; Fibroblasts/pathology ; Humans ; Metrorrhagia/diagnosis ; Metrorrhagia/etiology ; Partial Thromboplastin Time ; von Willebrand Disease, Type 1/complications
Raport
Tytuł:
Spontaneous recurrent hematuria and hematospermia: Unique manifestations of von Willebrand disease type I. Case report.
Autorzy:
Minardi D; Department of Clinic and Specialistic Sciences, Institue of Urology, Polytechnic University of the Marche Region, A.O. Ospedali Riuniti, Ancona. .
Scortechini AR
Milanese G
Leoni P
Muzzonigro G
Pokaż więcej
Źródło:
Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica [Arch Ital Urol Androl] 2016 Mar 31; Vol. 88 (1), pp. 62-3. Date of Electronic Publication: 2016 Mar 31.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Hematuria/*etiology
Hemospermia/*etiology
von Willebrand Disease, Type 1/*diagnosis
Adult ; Humans ; Male ; Recurrence ; Urinary Bladder/pathology ; von Willebrand Disease, Type 1/physiopathology
Czasopismo naukowe
Tytuł:
Increased amounts of von Willebrand factor are bound to microparticles after infusion of desmopressin.
Autorzy:
Trummer A; Department of Haematology, Haemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany. />Haarmeijer B
Werwitzke S
Wermes C
Ganser A
Budde U
Tiede A
Pokaż więcej
Źródło:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2013 Mar; Vol. 19 (2), pp. 236-41. Date of Electronic Publication: 2012 Oct 11.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Blood Platelets/*metabolism
Cell-Derived Microparticles/*metabolism
Deamino Arginine Vasopressin/*administration & dosage
Hemostasis/*drug effects
Hemostatics/*administration & dosage
von Willebrand Disease, Type 1/*drug therapy
von Willebrand Factor/*metabolism
Adult ; Annexin A5/blood ; Female ; Humans ; Infusions, Intravenous ; Male ; Middle Aged ; Young Adult ; von Willebrand Disease, Type 1/blood
Czasopismo naukowe
Tytuł:
Distinguishing types 1 and 2M von Willebrand disease.
Autorzy:
Favaloro EJ; Department of Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), Westmead Hospital, Westmead, NSW, Australia. />Forsyth C
Koutts J
Pokaż więcej
Źródło:
International journal of laboratory hematology [Int J Lab Hematol] 2012 Feb; Vol. 34 (1), pp. 102-5. Date of Electronic Publication: 2011 Jul 27.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
von Willebrand Disease, Type 1/*diagnosis
von Willebrand Disease, Type 2/*diagnosis
Adult ; Diagnosis, Differential ; Female ; Humans ; Mutation, Missense ; von Willebrand Disease, Type 1/genetics ; von Willebrand Disease, Type 2/genetics ; von Willebrand Factor/genetics
Czasopismo naukowe
Tytuł:
Use of autologous platelet-rich clots for the prevention of local injury bleeding in patients with severe inherited mucocutaneous bleeding disorders.
Autorzy:
Nurden P; Centre de Référence des Pathologies Plaquettaires, Hôpital Xavier Arnozan, Pessac, France. />Youlouz-Marfak I
Siberchicot F
Kostrzewa E
Andia I
Anitua E
Nurden AT
Pokaż więcej
Źródło:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2011 Jul; Vol. 17 (4), pp. 620-4. Date of Electronic Publication: 2011 Feb 16.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Platelet-Rich Plasma*
Postoperative Hemorrhage/*prevention & control
Thrombasthenia/*therapy
von Willebrand Disease, Type 1/*therapy
von Willebrand Disease, Type 2/*therapy
Female ; Humans ; Male ; Middle Aged ; Thrombasthenia/surgery ; Transplantation, Autologous ; von Willebrand Disease, Type 1/surgery ; von Willebrand Disease, Type 2/surgery
Czasopismo naukowe
Tytuł:
Successful treatment of an injury bleeding on a patient suffering from mild von Willebrand's disease and predisposition to allergic diseases, with recombinant factor VIIA.
Autorzy:
Alesci S
Krekeler S
Miesbach W
Pokaż więcej
Źródło:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2011 May; Vol. 17 (3), pp. 545-6. Date of Electronic Publication: 2010 Nov 11.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Factor VIIa/*therapeutic use
Hemorrhage/*drug therapy
Hypersensitivity/*complications
von Willebrand Disease, Type 1/*drug therapy
Accidents, Traffic ; Aged ; Female ; Hemorrhage/etiology ; Humans ; Recombinant Proteins/therapeutic use ; Treatment Outcome ; von Willebrand Disease, Type 1/complications
Raport
Tytuł:
Haemophilia A and von Willebrand's disease.
Autorzy:
Goodeve AC; Department of Cardiovascular Science, University of Sheffield, Sheffield, UK. />Rosén S
Verbruggen B
Pokaż więcej
Źródło:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2010 Jul; Vol. 16 Suppl 5, pp. 79-84.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Factor VIII/*analysis
Hemophilia A/*blood
von Willebrand Disease, Type 1/*blood
von Willebrand Factor/*analysis
Blood Coagulation Factor Inhibitors/analysis ; Enzyme-Linked Immunosorbent Assay ; Hemophilia A/genetics ; Humans ; Mutation ; von Willebrand Disease, Type 1/genetics ; von Willebrand Factor/genetics
Czasopismo naukowe
Tytuł:
Bleeding score in Type 1 von Willebrand disease patients using the ISTH-BAT questionnaire.
Autorzy:
Pathare A; Department of Haematology, College of Medicine & Health Sciences, Sultan Qaboos University Hospital, Muscat, Oman.
Al Omrani S; Department of Haematology, College of Medicine & Health Sciences, Sultan Qaboos University Hospital, Muscat, Oman.
Al Hajri F; Department of Haematology, College of Medicine & Health Sciences, Sultan Qaboos University Hospital, Muscat, Oman.
Al Obaidani N; Department of Haematology, College of Medicine & Health Sciences, Sultan Qaboos University Hospital, Muscat, Oman.
Al Balushi B; Department of Haematology, College of Medicine & Health Sciences, Sultan Qaboos University Hospital, Muscat, Oman.
Al Falahi K; Department of Haematology, College of Medicine & Health Sciences, Sultan Qaboos University Hospital, Muscat, Oman.
Pokaż więcej
Źródło:
International journal of laboratory hematology [Int J Lab Hematol] 2018 Apr; Vol. 40 (2), pp. 175-180. Date of Electronic Publication: 2017 Nov 08.
Typ publikacji:
Journal Article
MeSH Terms:
Hemorrhage/*diagnosis
von Willebrand Disease, Type 1/*complications
Adolescent ; Adult ; Child ; Female ; Humans ; Male ; Middle Aged ; Severity of Illness Index ; Surveys and Questionnaires ; Young Adult ; von Willebrand Factor/analysis
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies